[{"Assets_0_Q3_USD":686244000.0,"CommonStockSharesOutstanding_0_Q3_shares":56714788.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":83951000.0,"NetIncomeLoss_1_Q3_USD":-10224000.0,"NetIncomeLoss_3_Q3_USD":53787000.0,"StockholdersEquity_0_Q3_USD":610237000.0,"EarningsPerShareBasic_1_Q3_USD":-0.18,"EarningsPerShareBasic_3_Q3_USD":0.95,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":56643075.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":56449678.0,"Ticker":"XNCR","CIK":"1326732","name":"XENCOR INC","OfficialName":"Xencor Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574633486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]